Publications by authors named "Maria Gerogianni"

Article Synopsis
  • Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease linked to metabolic syndrome and conditions like insulin resistance, obesity, and diabetes, which increase cardiovascular risks.
  • Endothelial dysfunction is a key factor in the progression of heart diseases such as atherosclerosis and coronary artery disease in individuals with NAFLD.
  • The review aims to explore the connections between NAFLD and coronary artery disease, including the underlying mechanisms, genetic factors, and effective management strategies for patients.
View Article and Find Full Text PDF

Tea consumption is increasingly recognized for its potential benefits to cardiovascular health. This study reviews the available research, concentrating on the major components of tea and their mechanisms of action in the cardiovascular system. Tea is abundant in bioactive compounds, such as flavonoids and polysaccharides, which possess significant antioxidant and anti-inflammatory properties.

View Article and Find Full Text PDF

: Real-world data show limited utilization of direct oral anticoagulants (DOACs) in obese patients (body mass index [BMI] ≥ 30 kg/m) due to concerns regarding their efficacy and safety in this demographic. : This review aimed to consolidate current evidence on the efficacy and safety of DOACs versus warfarin in obese patients with non-valvular atrial fibrillation (AF) or venous thromboembolism (VTE). The primary efficacy outcome assessed a composite of all-cause mortality, stroke, systemic embolism (SE), and myocardial infarction (MI).

View Article and Find Full Text PDF

Background: Aloe vera is a popular medicinal plant used widely by the cosmetic, pharmaceutical, and food industries. The A. vera leaf gel, which is used mostly for its positive effects on human health, contains over 75 different bioactive compounds, including aloin.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Maria Gerogianni"

  • - Maria Gerogianni's recent research explores the interplay between metabolic disorders and cardiovascular health, highlighting how conditions like non-alcoholic fatty liver disease (NAFLD) and obesity contribute to endothelial dysfunction and increase the risk of coronary artery disease (CAD).
  • - She investigates the cardiovascular benefits of tea consumption, emphasizing the mechanisms of action of its bioactive compounds, which may hold promise for heart health through their antioxidant and anti-inflammatory effects.
  • - Her systematic review on the efficacy and safety of direct oral anticoagulants (DOACs) versus warfarin in obese patients with comorbidities provides valuable insights, revealing a lack of confidence in utilizing DOACs despite their benefits, underlining the need for further investigation in this demographic.